Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco 94158, California, United States.
Department of Pediatrics, Division of Hematology and Oncology, University of California, San Francisco, San Francisco 94158, California, United States.
J Chem Theory Comput. 2022 Oct 11;18(10):6251-6258. doi: 10.1021/acs.jctc.2c00526. Epub 2022 Sep 27.
KIT is a type 3 receptor tyrosine kinase that plays a crucial role in cellular growth and proliferation. Mutations in KIT can dysregulate its active-inactive equilibrium. Activating mutations drive cancer growth, while deactivating mutations result in the loss of skin and hair pigmentation in a disease known as piebaldism. Here, we propose a method based on molecular dynamics and free energy calculations to predict the functional effect of KIT mutations. Our calculations may have important clinical implications by defining the functional significance of previously uncharacterized KIT mutations and guiding targeted therapy.
KIT 是一种 3 型受体酪氨酸激酶,在细胞生长和增殖中发挥着关键作用。KIT 中的突变会使其活性-非活性平衡失调。激活突变驱动癌症生长,而失活突变则导致一种称为斑驳病的疾病中皮肤和头发色素的丧失。在这里,我们提出了一种基于分子动力学和自由能计算的方法来预测 KIT 突变的功能影响。我们的计算方法可能具有重要的临床意义,通过定义以前未表征的 KIT 突变的功能意义,并指导靶向治疗。